^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    lorvotuzumab mertansine (IMGN901)

    i
    Company:
    AbbVie
    Drug class:
    Microtubule inhibitor, CD56-targeted antibody-drug conjugate
    Related drugs: